LANXESS Tidigare resultatutveckling
Tidigare kriterier kontrolleras 0/6
LANXESS s intäkter har minskat med en genomsnittlig årlig takt på -56%, medan Chemicals -branschen såg intäkter på sjunkande 4.4% årligen. Intäkterna har varit fallande med en genomsnittlig takt på 2% per år.
Viktig information
-55.95%
Tillväxttakt i vinsten
-55.95%
Tillväxttakt för EPS
| Chemicals Tillväxt i branschen | 12.41% |
| Intäkternas tillväxttakt | -2.05% |
| Avkastning på eget kapital | -18.87% |
| Nettomarginal | -12.13% |
| Nästa resultatuppdatering | 07 Aug 2026 |
Senaste uppdateringar av tidigare prestationer
Recent updates
Analysartikel • May 09
Here's What Analysts Are Forecasting For LANXESS Aktiengesellschaft (ETR:LXS) After Its First-Quarter Results
LANXESS Aktiengesellschaft ( ETR:LXS ) shareholders are probably feeling a little disappointed, since its shares fell...
Uppdatering av berättelse • May 01
LXS: Mixed Bank Ratings Will Drive Bullish Repricing On Higher Future P/E
Analysts have adjusted the price target on LANXESS from about €28.86 to about €26.29. This reflects updated views on faster revenue growth, much thinner profit margins, and a much higher assumed future P/E multiple after recent mixed rating changes from major banks.
Uppdatering av berättelse • Apr 16
LXS: Future Earnings Multiples Will Balance Mixed Ratings And Margin Execution Risk
LANXESS' updated analyst price target edges up to about €17.91 from roughly €17.81, as analysts factor in slightly higher assumed revenue growth and a marginally richer future P/E, partly offset by a more cautious profit margin view following mixed recent rating changes. Analyst Commentary Recent research views on LANXESS are mixed, with both upgrades and a downgrade pointing to different expectations around execution, earnings power and valuation risk.Uppdatering av berättelse • Apr 02
LXS: Future Earnings Multiples Will Reflect Mixed Rating Shifts And Execution Risk
Analysts have trimmed the LANXESS price target from about €18.66 to around €17.81, reflecting mixed recent research that balances reduced fair value and profit margin assumptions with updated views on growth and valuation following both target cuts and rating changes across the Street. Analyst Commentary Recent research on LANXESS shows a split tape, with some firms turning more positive on the shares while others are taking a more cautious line on execution and fair value assumptions.
Uppdatering av berättelse • Mar 19
LXS: Fair Outlook Balances Higher Risk Assumptions With Recent Upgrade
Analysts have trimmed their fair value estimate for LANXESS from €17.0 to €14.0, reflecting recent price target cuts such as Deutsche Bank's move to €17 and updated assumptions for growth, margins and risk, even as some research, including a recent Goldman Sachs upgrade, highlights potential longer term upside drivers. Analyst Commentary Recent research shows a split view on LANXESS, with some highlighting possible longer term drivers while others are reining in expectations.Uppdatering av berättelse • Mar 05
LXS: Upgrade And Reset Expectations Will Drive Bullish Repricing Potential
Analysts have adjusted their price targets on LANXESS, with the latest change lowering one view from €18.50 to €17. This reflects updated assumptions around discount rates, modest revenue growth and expected P/E levels.Uppdatering av berättelse • Feb 18
LXS: Upgrade And Margin Execution Are Expected To Drive Bullish Repricing
LANXESS's consensus analyst price target has moved modestly lower, with recent cuts to €17 and €15 cited by analysts who point to updated assumptions around discount rates, profit margins, and forward P/E expectations. Analyst Commentary Recent research on LANXESS highlights a mix of caution and optimism, with some bullish analysts focusing on potential upside if the company can execute against current expectations on margins and earnings quality.Uppdatering av berättelse • Feb 04
LXS: Sector Headwinds And Execution Discipline Will Drive Future Bullish Repricing
Analysts have trimmed their price expectations for LANXESS, reflected in a slightly lower fair value estimate of about €28.87 from €29.24. They cite a series of reduced Street price targets and more cautious sector views, even as underlying model assumptions such as revenue growth, profit margin and future P/E remain broadly consistent.Uppdatering av berättelse • Jan 21
LXS: Future Earnings Multiples Will Reward Execution Despite Sector Downgrades
Our fair value estimate for LANXESS has been reduced from about €20.30 to roughly €18.66, reflecting a cluster of lower price targets and more cautious views from analysts who now generally expect lower growth and apply a slightly higher required return. Analyst Commentary Recent Street research around LANXESS has tilted more cautious, with several firms trimming price targets and highlighting sector headwinds in European chemicals and ingredients.Uppdatering av berättelse • Jan 06
LXS: Earnings Resilience And Portfolio Actions Will Drive Bullish Repricing
Narrative Update The updated analyst price target framework for LANXESS points to a fair value adjustment from €31.85 to €29.24. This reflects recent target cuts from €21 to €15 at JPMorgan, a downgrade to Underweight with a €15 target at Barclays, and a reduction from €26 to €23 at Citi that collectively signal increased caution among analysts.Analysartikel • Jan 02
A Look At The Fair Value Of LANXESS Aktiengesellschaft (ETR:LXS)
Key Insights The projected fair value for LANXESS is €14.85 based on 2 Stage Free Cash Flow to Equity LANXESS' €17.62...Uppdatering av berättelse • Dec 17
LXS: Demand Recovery And Margin Actions Will Drive Bullish Repricing
Analysts have trimmed their price target on LANXESS to EUR 15 from EUR 21, citing weaker expected revenue growth, lower profit margins, a higher discount rate, and a richer future P E multiple. Together, these factors reduce estimated fair value from about EUR 37.49 to EUR 31.85 per share.Analysartikel • Dec 15
Does LANXESS (ETR:LXS) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Uppdatering av berättelse • Dec 03
LXS: Future Earnings Multiples Will Reward Improving Execution Amid Sector Caution
The analyst fair value estimate for LANXESS has been reduced slightly to EUR 20.30 from EUR 20.92, as analysts factor in lower sector sentiment, a modestly softer revenue growth outlook, and recent cuts to Street price targets across the European chemicals space. Analyst Commentary Street research on LANXESS has turned more cautious, with recent revisions reflecting concerns around sector headwinds, execution risk, and a less supportive valuation backdrop.Uppdatering av berättelse • Nov 19
LXS: Future Earnings Multiples Will Reflect Sector Caution And Resilient Performance
LANXESS’s analyst price target has been revised downward from €24.55 to €20.92 as analysts cite sector-wide caution and a reassessment of fair value within the European chemicals industry. Analyst Commentary The recent series of updates from street research highlights both supportive and cautious sentiment regarding LANXESS’s outlook, reflecting the evolving landscape in the European chemicals sector.Uppdatering av berättelse • Nov 05
LXS: Future Resilience Will Support Stability Amid Sector Pressures
Analysts have modestly reduced their price target for LANXESS by approximately EUR 0.30. This adjustment reflects more cautious growth and valuation assumptions in light of recent sector performance and peer comparisons.Uppdatering av berättelse • Oct 22
Analysts Lower LANXESS Price Target and Ratings Amid Mixed Outlook and Valuation Shifts
The analyst price target for LANXESS has been reduced by approximately EUR 0.67 to EUR 24.85. This change reflects revised expectations on revenue growth and profitability as analysts adjust their outlook in light of recent performance and updated industry assessments.Uppdatering av berättelse • Oct 08
Portfolio Optimization And Sustainable Initiatives Will Unlock Market Opportunities
The analyst consensus price target for LANXESS has been reduced from €26.79 to €25.52. Analysts cite increased caution due to reduced expected growth and valuation concerns following the company's recent outperformance among peers.Uppdatering av berättelse • Aug 29
Accelerated FORWARD! Program Set To Improve Future Performance
Analysts have lowered LANXESS's price target to €26.79, citing ongoing operational headwinds, margin pressure, and delayed recovery in key markets, while acknowledging that cost measures will take time to improve earnings. Analyst Commentary Bearish analysts cite persistent near-term operational headwinds and sluggish demand as reasons for lowering price targets.Analysartikel • Jul 03
Is LANXESS Aktiengesellschaft (ETR:LXS) Trading At A 46% Discount?
Key Insights Using the 2 Stage Free Cash Flow to Equity, LANXESS fair value estimate is €47.92 LANXESS is estimated to...
Ny berättelse • Mar 22
Accelerated FORWARD! Program Set To Improve Future Performance
Successful cost savings and portfolio transformation initiatives are boosting profitability, improving margins, and enhancing future earnings potential through strategic divestitures.Analysartikel • Mar 07
Why Investors Shouldn't Be Surprised By LANXESS Aktiengesellschaft's (ETR:LXS) 25% Share Price Surge
LANXESS Aktiengesellschaft ( ETR:LXS ) shareholders have had their patience rewarded with a 25% share price jump in the...Analysartikel • Jan 31
LANXESS (ETR:LXS) Use Of Debt Could Be Considered Risky
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analysartikel • Jan 07
Why We're Not Concerned About LANXESS Aktiengesellschaft's (ETR:LXS) Share Price
There wouldn't be many who think LANXESS Aktiengesellschaft's ( ETR:LXS ) price-to-sales (or "P/S") ratio of 0.3x is...Analysartikel • Oct 30
Does LANXESS (ETR:LXS) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analysartikel • Sep 07
Why We're Not Concerned About LANXESS Aktiengesellschaft's (ETR:LXS) Share Price
There wouldn't be many who think LANXESS Aktiengesellschaft's ( ETR:LXS ) price-to-sales (or "P/S") ratio of 0.3x is...Analysartikel • Jul 23
Is LANXESS (ETR:LXS) Using Debt Sensibly?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Analysartikel • May 27
Is It Too Late To Consider Buying LANXESS Aktiengesellschaft (ETR:LXS)?
While LANXESS Aktiengesellschaft ( ETR:LXS ) might not have the largest market cap around , it saw a double-digit share...Analysartikel • May 08
Why Investors Shouldn't Be Surprised By LANXESS Aktiengesellschaft's (ETR:LXS) P/S
There wouldn't be many who think LANXESS Aktiengesellschaft's ( ETR:LXS ) price-to-sales (or "P/S") ratio of 0.4x is...Analysartikel • Apr 20
Is There An Opportunity With LANXESS Aktiengesellschaft's (ETR:LXS) 42% Undervaluation?
Key Insights The projected fair value for LANXESS is €44.32 based on 2 Stage Free Cash Flow to Equity LANXESS is...Analysartikel • Mar 22
Is LANXESS (ETR:LXS) Weighed On By Its Debt Load?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analysartikel • Jan 27
What You Can Learn From LANXESS Aktiengesellschaft's (ETR:LXS) P/S
There wouldn't be many who think LANXESS Aktiengesellschaft's ( ETR:LXS ) price-to-sales (or "P/S") ratio of 0.3x is...Analysartikel • Dec 05
Is LANXESS (ETR:LXS) Using Too Much Debt?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analysartikel • Nov 01
A Look At The Fair Value Of LANXESS Aktiengesellschaft (ETR:LXS)
Key Insights The projected fair value for LANXESS is €20.51 based on Dividend Discount Model Current share price of...Fördelning av intäkter och kostnader
Fördelning av intäkter och kostnader
Hur LANXESS tjänar och spenderar pengar. Baserat på senast rapporterade resultat, på rullande tolvmånadersbasis.
Resultat- och intäktshistorik
| Datum | Intäkter | Intäkter | G+A Kostnader | FoU-kostnader |
|---|---|---|---|---|
| 31 Mar 26 | 5,450 | -661 | 1,065 | 93 |
| 31 Dec 25 | 5,673 | -577 | 1,091 | 96 |
| 30 Sep 25 | 5,888 | -243 | 1,118 | 97 |
| 30 Jun 25 | 6,148 | -165 | 1,164 | 102 |
| 31 Mar 25 | 6,360 | -136 | 1,176 | 105 |
| 31 Dec 24 | 6,366 | -177 | 1,177 | 104 |
| 30 Sep 24 | 6,319 | -690 | 1,167 | 105 |
| 30 Jun 24 | 6,322 | -822 | 1,164 | 102 |
| 31 Mar 24 | 6,422 | -951 | 1,182 | 100 |
| 31 Dec 23 | 6,714 | -843 | 1,238 | 99 |
| 30 Sep 23 | 7,251 | -280 | 1,350 | 102 |
| 30 Jun 23 | 7,835 | -65 | 1,438 | 104 |
| 31 Mar 23 | 8,056 | 128 | 1,439 | 105 |
| 31 Dec 22 | 8,088 | 184 | 1,398 | 102 |
| 30 Sep 22 | 7,794 | 191 | 1,330 | 100 |
| 30 Jun 22 | 7,190 | 147 | 1,229 | 99 |
| 31 Mar 22 | 6,660 | 146 | 1,171 | 96 |
| 31 Dec 21 | 6,101 | 116 | 1,107 | 95 |
| 30 Sep 21 | 5,925 | 119 | 1,050 | 99 |
| 30 Jun 21 | 5,805 | 105 | 1,018 | 100 |
| 31 Mar 21 | 5,772 | 863 | 1,022 | 105 |
| 31 Dec 20 | 6,104 | 892 | 1,056 | 108 |
| 30 Sep 20 | 6,237 | 883 | 1,088 | 110 |
| 30 Jun 20 | 6,480 | 938 | 1,110 | 113 |
| 31 Mar 20 | 6,768 | 231 | 1,127 | 113 |
| 31 Dec 19 | 6,802 | 255 | 1,115 | 114 |
| 30 Sep 19 | 6,559 | 266 | 1,055 | 105 |
| 30 Jun 19 | 6,641 | 243 | 1,066 | 106 |
| 31 Mar 19 | 6,746 | 212 | 1,072 | 106 |
| 31 Dec 18 | 6,824 | 190 | 1,084 | 109 |
| 30 Sep 18 | 7,066 | 144 | 1,166 | 110 |
| 30 Jun 18 | 6,990 | 138 | 1,167 | 109 |
| 31 Mar 18 | 6,873 | 63 | 1,165 | 110 |
| 31 Dec 17 | 6,530 | 23 | 1,111 | 103 |
| 30 Sep 17 | 6,810 | 73 | 1,103 | 116 |
| 30 Jun 17 | 7,021 | 83 | 1,087 | 121 |
| 31 Mar 17 | 7,252 | 166 | 1,072 | 124 |
| 31 Dec 16 | 7,699 | 192 | 1,116 | 131 |
| 30 Sep 16 | 7,590 | 205 | 1,092 | 128 |
| 30 Jun 16 | 7,622 | 184 | 1,093 | 126 |
| 31 Mar 16 | 7,784 | 196 | 1,097 | 128 |
| 31 Dec 15 | 7,902 | 165 | 1,078 | 130 |
| 30 Sep 15 | 8,000 | 82 | 1,060 | 134 |
| 30 Jun 15 | 8,087 | 76 | 1,048 | 141 |
Kvalitetsintäkter: LXS är för närvarande olönsam.
Växande vinstmarginal: LXS är för närvarande olönsam.
Fritt kassaflöde vs resultatanalys
Analys av tidigare vinsttillväxt
Resultatutveckling: LXS är olönsam och förlusterna har ökat under de senaste 5 åren i en takt av 56% per år.
Accelererande tillväxt: Det går inte att jämföra LXS s intäktstillväxt under det senaste året med dess 5-åriga genomsnitt eftersom det för närvarande är olönsamt
Resultat vs industri: LXS är olönsam, vilket gör det svårt att jämföra det senaste årets vinsttillväxt med Chemicals branschen ( -13.5% ).
Avkastning på eget kapital
Hög ROE: LXS har en negativ avkastning på eget kapital ( -18.87% ), eftersom det för närvarande är olönsamt.
Avkastning på tillgångar
Avkastning på sysselsatt kapital
Upptäck starka bolag som tidigare presterat bra
Företagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/05/22 21:13 |
| Aktiekurs vid dagens slut | 2026/05/22 00:00 |
| Intäkter | 2026/03/31 |
| Årlig intjäning | 2025/12/31 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som användes för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och tutorials på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
LANXESS Aktiengesellschaft bevakas av 35 analytiker. 15 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| James Knight | Barclays |
| Anil Shenoy | Barclays |
| Andres Castanos-Mollor | Berenberg |